High use of intravenous immunoglobulin (IVIG) in Australian patients with myasthenia gravis may be due to underuse of other steroid-sparing immunosuppressants (SSI), a Victorian study suggests. A review of the management of 66 patients with MG at a Victorian neurology centre found that in most aspects their disease features and treatment were generally consistent with ...
High rates of IVIG use found in myasthenia gravis review
By Michael Woodhead
11 Dec 2019